⌘K

16:26:16·17d

SECFiling

SEC Form DEFA14A filed by NeoGenomics Inc.

NEO· NeoGenomics Inc.

Health Care

Original source

Companies

NEO
NeoGenomics Inc.
Health Care

Recent analyst ratings

Jul 30UpdateBTIG Research-
Jul 29UpdateWilliam Blair-
May 15UpdateGuggenheim-
Apr 30UpdateLeerink Partners$9.00
Jan 13UpdateThe Benchmark Company-
Dec 10UpdateJefferies$22.00

Related

PR23h
NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
PR10d
NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
PR16d
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
SEC17d
SEC Form DEF 14A filed by NeoGenomics Inc.
INSIDER20d
SEC Form 4 filed by Stone Warren
INSIDER20d
SEC Form 4 filed by Zook Anthony P.
SEC27d
Amendment: SEC Form SCHEDULE 13G/A filed by NeoGenomics Inc.
PR38d
NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling